CL
CLVR.US Clever Leaves Holdings Inc
- Market cap
- USD 1.75K
- P/E
- -
- P/B
- -
- ROE
- -84.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2024.
Is CLVR.US undervalued?
Graham numberThe Graham number of Clever Leaves Holdings Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Clever Leaves Holdings Inc fundamental analysis
No fundamental analysis for Clever Leaves Holdings Inc yet.
Clever Leaves Holdings Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Clever Leaves Holdings Inc
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, market…
Full company profileClever Leaves Holdings Inc financial statements
2024 annualized: Fiscal year 2024 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2024, the balance sheet is the latest quarter. Figures change when the annual report is published.
Clever Leaves Holdings Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | - | 7.83M | 12.1M | 15.4M | 16.4M | 17.4M | 18.6M |
| Gross Profit | -99.0K | 3.10M | 7.41M | 6.81M | 4.33M | 6.56M | -1.38M |
| Operating Income | -5.41M | -36.5M | -26.8M | -38.7M | -21.5M | -15.6M | -19.6M |
| EBITDA | -5.31M | -41.7M | -17.8M | -34.4M | -37.8M | -16.8M | -18.4M |
| Net Income | 7.36M | -46.0M | -36.1M | -45.6M | -66.1M | -17.9M | -20.3M |
| EPS | - | -177 | -44 | -53 | -52 | -11 | -12 |
| Balance Sheet | |||||||
| Total Assets | 68.7M | 95.7M | 166M | 116M | 52.1M | 31.2M | 31.2M |
| Total Liabilities | 26.1M | 45.5M | 51.6M | 43.4M | 11.7M | 7.03M | 7.03M |
| Shareholders' Equity | 29.7M | 45.5M | 114M | 72.8M | 40.4M | 24.2M | 24.2M |
| Cash & Short-term Investments | 21.3M | 12.0M | 79.5M | 37.2M | 12.4M | 6.83M | 6.83M |
| Total Debt | 14.2M | 33.7M | 34.7M | 25.1M | 3.86M | 2.09M | 2.09M |
| Cash Flow | |||||||
| Operating Cash Flow | -4.28M | -37.1M | -22.0M | -36.2M | -29.1M | -11.5M | -6.17M |
| Capital Expenditure | 4.47M | 18.7M | 3.67M | 7.28M | 1.31M | 31.0K | 624K |
| Free Cash Flow | -8.74M | -55.7M | -25.6M | -43.5M | -30.4M | -11.5M | -5.55M |
| Ratios | |||||||
| ROE | 24.8% | -101.1% | -31.6% | -62.7% | -163.6% | -73.9% | -84.0% |
| ROA | 10.7% | -48.0% | -21.8% | -39.3% | -126.9% | -57.3% | -65.1% |
| Net Profit Margin | - | -586.9% | -298.0% | -296.8% | -402.8% | -102.8% | -109.6% |
| Debt to Equity | 0.48x | 0.74x | 0.30x | 0.34x | 0.10x | 0.09x | 0.09x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Clever Leaves Holdings Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 10.7M | 13 | - |
| 2019 | - | - | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:30 on Aug 25, 2023.
Who owns Clever Leaves Holdings Inc
- Insiders 0.00%
- Institutions 0.22%
- Public & others 99.78%
- Shares outstanding 1.75M
- Free float 1.43M
Top funds holding CLVR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| AdvisorShares Pure Cannabis ETF | 34.6K | 1.97% | 0.00% | Apr 2024 |
| Vanguard Institutional Extnd Mkt Idx Tr | 15.1K | 0.86% | 0.00% | Apr 2024 |
| Fidelity Extended Market Index | 7.45K | 0.42% | 0.00% | Mar 2024 |
| Amplify Seymour Cannabis ETF | 5.09K | 0.29% | 0.00% | Apr 2024 |
| Fidelity Total Market Index | 1.25K | 0.07% | 0.00% | Mar 2024 |
| BlackRock Extended Mkt Composite | 1.22K | 0.07% | -0.08% | Sep 2023 |
| BlackRock Extended Equity Market K | 1.06K | 0.06% | 0.00% | Mar 2024 |
| Fidelity Series Total Market Index | 1.03K | 0.06% | 0.00% | Mar 2024 |
| NT Ext Equity Mkt Idx Fd - L | 707.00 | 0.04% | 0.00% | Mar 2024 |
| Northern Trust Extended Eq Market Idx | 707.00 | 0.04% | 0.00% | Mar 2024 |
| NT Ext Equity Mkt Idx Fd - NL | 529.00 | 0.03% | 0.00% | Mar 2024 |
| Fidelity Nasdaq Composite Index | 475.00 | 0.03% | 0.00% | Mar 2024 |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 425.00 | 0.02% | +0.24% | Dec 2023 |
| Spartan Total Market Index Pool E | 395.00 | 0.02% | 0.00% | Mar 2024 |
| State St US Extended Mkt Indx NL Cl C | 246.00 | 0.01% | 0.00% | Apr 2024 |
| SSgA U.S. Extended Market Index Class I | 246.00 | 0.01% | 0.00% | Dec 2023 |
| Extended Equity Market Fund M | 131.00 | 0.01% | 0.00% | Mar 2024 |
| State St US Ttl Mkt Indx SL Cl I | 123.00 | 0.01% | 0.00% | Apr 2024 |
| NT US Market Cap Idx Fd - L | 73.00 | 0.00% | 0.00% | Dec 2023 |
| Northern Trust Wilshire 5000 | 73.00 | 0.00% | 0.00% | Mar 2024 |
Top institutions holding CLVR.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| AdvisorShares Investments, LLC | 34.6K | 1.97% | -1.45% | Dec 2023 |
| Renaissance Technologies Corp | 34.3K | 1.96% | +20.54% | Dec 2023 |
| Vanguard Group Inc | 15.1K | 0.86% | 0.00% | Mar 2024 |
| Geode Capital Management, LLC | 10.6K | 0.61% | -0.01% | Dec 2023 |
| BlackRock Inc | 9.94K | 0.57% | 0.00% | Dec 2023 |
| Amundi | 8.44K | 0.48% | 0.00% | Dec 2023 |
| Penserra Capital Management, LLC | 5.09K | 0.29% | 0.00% | Dec 2023 |
| Tower Research Capital LLC | 2.18K | 0.12% | +205.91% | Dec 2023 |
| Morgan Stanley - Brokerage Accounts | 44.00 | 0.00% | 0.00% | Dec 2023 |
| Royal Bank of Canada | 26.00 | 0.00% | 0.00% | Dec 2023 |
| Advisor Group Holdings, Inc. | 16.00 | 0.00% | 0.00% | Dec 2023 |
| Wells Fargo & Co | 12.00 | 0.00% | -82.61% | Dec 2023 |
| UBS Group AG | 11.00 | 0.00% | -99.29% | Dec 2023 |
| Focused Wealth Strategies, INC. | 6.00 | 0.00% | 0.00% | Dec 2023 |
| FNY Investment Advisers, LLC | 0.00 | 0.00% | -100.00% | Dec 2023 |
Clever Leaves Holdings Inc company profile
- Company name
- Clever Leaves Holdings Inc
- Ticker
- CLVR.US
- ISIN
- CA1867601041
- Exchange
- USA Stocks
- Listed since
- Dec 18, 2020
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 296
- Fiscal year end
- December
- Address
- Bodega 19-B, Parque Ind. Tibitoc P.H, Tocancipá, Colombia, 251017
- Phone
- 561 634 7430
- Website
- cleverleaves.com
About Clever Leaves Holdings Inc
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
Clever Leaves Holdings Inc management
9- Mr. Andres FajardoCo-Founder, CEO & Director · born 1978
- Mr. Henry R. Hague IIIChief Financial Officer · born 1972
- Mr. Julian WilchesChief Regulatory Officer · born 1979
- Mr. Gustavo EscobarChief Operating Officer
- Ms. Marta Pinto LeiteGeneral Counsel & Corporate Secretary
- Mr. Andrew MillerHead of Business Development
- Mr. Camilo BohorquezHead of Colombia
- Ms. Caroline KliessManaging Director of Germany
- Ms. Jackie KeshnerInvestor Relations Executive